Literature DB >> 898025

A prospective study of combined ultrasonography and needle aspiration biopsy in the assessment of the hypofunctioning thyroid nodule.

P G Walfish, E Hazani, H T Strawbridge, M Miskin, I B Rosen.   

Abstract

Mesh:

Year:  1977        PMID: 898025

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  8 in total

Review 1.  Problems in the management of solitary nodules and diffuse goitres.

Authors:  A J Webb
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

2.  Solitary thyroid nodule--what to do?

Authors:  V K Kapoor; S S Sikora
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

3.  Morphometric analysis of thyroid cell aspirates.

Authors:  R G Wright; H Castles; R H Mortimer
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

4.  A prospective controlled study of fine-needle aspiration and Tru-cut needle biopsy of dominant thyroid nodules.

Authors:  J Boey; C Hsu; R J Collins; J Wong
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

5.  The utility of fine needle aspiration biopsy cytology in the management of thyroid tumors.

Authors:  J E Varhaug; E Segadal; P Heimann
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

6.  Management of isolated thyroid swellings: a prospective six year study of fine needle aspiration cytology in diagnosis.

Authors:  E L Cusick; C A MacIntosh; Z H Krukowski; V M Williams; S W Ewen; N A Matheson
Journal:  BMJ       Date:  1990-08-11

7.  Reduced serum thyroglobulin response to bovine TSH in malignant hypofunctioning solid thyroid nodules: comparison to benign nodular disease.

Authors:  Z Leite; P Carneiro; A Halpern; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

8.  Cytofluorimetric measurements on the DNA contents of tumor cells in human thyroid gland.

Authors:  G L Lukács; G Balázs; I Zs-Nagy
Journal:  J Cancer Res Clin Oncol       Date:  1979       Impact factor: 4.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.